Potential Type 1 Diabetes Therapy Studied
Posted on: Thursday, 28 August 2008, 12:01 CDT
U.S. scientists say they confirmed in human experiments a potential type 1 diabetes therapy that might reverse the disease.
Researchers led by Dr. Denise Faustman, director of the Massachusetts General Hospital's immunobiology laboratory, confirmed the mechanism behind the potential new therapy. The scientists showed blocking a metabolic pathway regulating the immune system eliminated immune cells that react against a patient's own tissues.
Faustman and her team previously discovered a technique that reversed type 1 diabetes in a mouse model. They said the current study is the first demonstration of the strategy in humans and supports the viability of a phase I clinical trial that is under way.
"Our studies in mice showed that we could selectively kill the defective autoimmune cells that were destroying insulin-producing islets," said Faustman. "These results show that the same selective destruction can occur in human cells and connect what we saw in our animal studies with the protocol we are pursuing in our Phase I clinical trial."
The research is reported in the early online issue of the Proceedings of the National Academy of Sciences.
Source: United Press International
Related Articles
- The Recessive Epigenetic Swellmap Mutation Affects the Expression of Two Step II Splicing Factors Required for the Transcription of the Cell Proliferation Gene STRUWWELPETER and for the Timing of Cell Cycle Arrest in the Arabidopsis Leaf
- Glycosylphosphatidylinositol-Anchored Proteins Are Required for Cell Wall Synthesis and Morphogenesis in Arabidopsis
- Regeneration of the Pancreatic [Beta] Cell
- Transplantation and Islet Topics
- Spleen Surprise Source of Stem Cells
- Perturbation of NgTRF1 Expression Induces Apoptosis-Like Cell Death in Tobacco BY-2 Cells and Implicates NgTRF1 in the Control of Telomere Length and Stability
- The DHE Cell Line As a Model for Studying Rat Gastro-Intestinal Mucin Expression: Effects of Dexamethasone
- Stimulation of Quiescent Cells By Individual Polypeptide Growth Factors is Limited to One Cell Cycle
- In Vivo and In Vitro Characterization of Insulin-Producing Cells Obtained From Murine Bone Marrow
- Diabetes Research Fuels Embryo Stem Cell Debate
 |
 |
User Comments (0)
RSS Feeds